AI cancer cures slowed by chip shortage, says UK's biggest tech boss

AI cancer cures slowed by chip shortage, says UK's biggest tech boss

The head of chip designer Arm says modelling how a DNA marker is impacted by cancer cannot be done now, but computers are "going to solve it".

Arm's CEO warns chip shortage hampers AI cancer research

Arm CEO Rene Haas says AI could help cure cancer but chip shortages make DNA marker modeling too complex for current systems, calling health AI's

Arm’s CEO warns chip shortage hampers AI cancer research

The chip shortage delays AI advancements in cancer research, potentially slowing breakthroughs in treatment and drug discovery. The post Arm’s CEO warns chip shortage hampers AI cancer research appeared first on Crypto Briefing .

Arm CEO Rene Haas Says Chip Shortages Are Slowing Down AI Cancer Research

Arm CEO Rene Haas told the BBC that AI could eventually crack cancer by modeling how DNA markers drive tumors, but said the breakthrough is being held back by a shortage of chips needed to build AI data centers. He also predicted humanoid robots doing repair and manufacturing work within a decade and downplayed fears of mass AI job losses.

AI cancer cures slowed by chip shortage, says UK’s biggest tech boss

Rene Haas was previously on the board of British pharmaceutical giant AstraZeneca The boss of the biggest UK-headquartered tech firm has said that artificial intelligence will find a cure for cancer that humans cannot in our lifetimes. Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings, said that while modelling how a DNA marker is impacted by cancer is currently “too complex” a problem, computers are “going to solve it” in…